Nature Communications · 2024 · 44 citations · 32 references
MedicineMolecular BiologyOncologyCancer ImmunologyMolecular OncologyTumor ImmunologyCancer ImmunotherapyCytokines In Tumor ImmunityHuman Papillomavirus InfectionNoncoding Rna In CancerOncogenic VirusesSquamous Cell CarcinomaAdaptive Immune EvasionE7 ExpressionE7 OncoproteinHpv Immune EvasionHpv OncogenesisImmune Evasion Physiology
Immune evasion represents a crucial milestone in the progression of cancer and serves as the theoretical foundation for tumor immunotherapy. In this study, we reveal a negative association between Human Papillomavirus (HPV)-encoded circular RNA, circE7, and the infiltration of CD8+ T cells in head and neck squamous cell carcinoma (HNSCC). Both in vitro and in vivo experiments demonstrate that circE7 suppresses the function and activity of T cells by downregulating the transcription of LGALS9, which encodes the galectin-9 protein. The molecular mechanism involves circE7 binding to acetyl-CoA carboxylase 1 (ACC1), promoting its dephosphorylation and thereby activating ACC1. Activated ACC1 reduces H3K27 acetylation at the LGALS9 gene promoter, leading to decreased galectin-9 expression. Notably, galectin-9 interacts with immune checkpoint molecules TIM-3 and PD-1, inhibiting the secretion of cytotoxic cytokines by T cells and promoting T cell apoptosis. Here, we demonstrate a mechanism by which HPV promotes immune evasion in HNSCC through a circE7-driven epigenetic modification and propose a potential immunotherapy strategy for HNSCC that involves the combined use of anti-PD-1 and anti-TIM-3 inhibitors. Immune evasion is a feature of HPV-positive head and neck squamous cell carcinoma (HNSCC). Here the authors report that a circular RNA, circE7, encoded by HPV promotes immune evasion in HNSCC by promoting downregulation of galectin-9.
32
An integrated encyclopedia of DNA elements in the human genome
Ronny Lorenz, Christian Höner zu Siederdissen, Hakim Tafer et al. · Algorithms for Molecular Biology · 2011 · 5.4K citations · Full text
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text
Medicine, Oncology, Metastasis +5
Comprehensive genomic characterization of head and neck squamous cell carcinomas